r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

CW

Colin Walsh

Insider · Director · ATTO

Colin Walsh files insider transactions with the SEC as a director of Attovia Therapeutics (ATTO). We hold 6 disclosed purchases and sales filed since 28 June 2021, 6 of them in the last 90 days.

  • Files forATTO
  • Disclosed buys and sells6 in all, 6 in the last 90 days
  • Last disclosure28 August 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 5 August 2026 — 6 August 2026Director · Attovia Therapeutics (ATTO)64 Form 4 lines · source: SEC Form 4
  • Filed 24 June 2021 — 16 June 2023Director · Elevation Oncology (ELEV)3 Form 4 lines · source: SEC Form 4

Everything they disclosed

67 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.